Literature DB >> 14988302

Insulin sensitivity, insulinemia, and coronary artery disease: the Insulin Resistance Atherosclerosis Study.

Marian Rewers1, Daniel Zaccaro, Ralph D'Agostino, Steven Haffner, Mohammed F Saad, Joe V Selby, Richard Bergman, Peter Savage.   

Abstract

OBJECTIVE: The aim of this study was to evaluate whether low insulin sensitivity (Si) measured using a modified frequently sampled intravenous glucose tolerance test with minimal model analysis is associated with coronary artery disease (CAD) independent of other cardiovascular risk factors. RESEARCH DESIGN AND METHODS: We studied 1,482 women and men, age 40-69 years old, African American (28%), Hispanic (34%), or non-Hispanic white (38%), with normal (45%), impaired (23%), or diabetic (32%) glucose tolerance. CAD defined as confirmed past myocardial infarction, coronary artery bypass graft, coronary angioplasty, or presence of a major Q-wave was found in 91 participants.
RESULTS: The odds ratio (OR) for CAD was greatest among individuals in the two lowest quintiles of Si (2.4, 95% CI 1.0-5.6 and 4.7, 2.1-10.7) compared with the highest Si quintile. After adjusting for demographic and cardiovascular risk factors, a decrement from the 75th to 25th percentile in Si was associated with a 56% increase in CAD (P=0.028). Similar increments in fasting or 2-h insulin levels were associated with, respectively, only 15 (NS) and 3% (NS) increases in CAD. The association between Si and CAD was partially mediated by insulin, HDL cholesterol and triglyceride levels, hypertension, diabetes, and obesity, but not LDL cholesterol or cigarette smoking.
CONCLUSIONS: Low Si is associated with CAD independently of and stronger than plasma insulin levels. Part of the association is accounted for by dyslipidemia, hypertension, diabetes, and obesity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14988302     DOI: 10.2337/diacare.27.3.781

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  25 in total

1.  Hyperinsulinemia does not change atherosclerosis development in apolipoprotein E null mice.

Authors:  Christian Rask-Madsen; Erica Buonomo; Qian Li; Kyoungmin Park; Allen C Clermont; Oluwatobi Yerokun; Mark Rekhter; George L King
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-15       Impact factor: 8.311

Review 2.  Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.

Authors:  Christian K Roberts; Andrea L Hevener; R James Barnard
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

3.  Risk factors for development of cardiovascular complications in patients with chronic renal disease and diabetic nephropathy.

Authors:  Amra Mataradzija; Halima Resić; Senija Rasić; Nihad Kukavica; Fahrudin Masnić
Journal:  Bosn J Basic Med Sci       Date:  2010-04       Impact factor: 3.363

4.  Prevention of coronary heart disease in diabetes.

Authors:  James B Meigs
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-08

Review 5.  Management of type 2 diabetes mellitus. Role of thiazolidinediones.

Authors:  Jason Noble; Mark O Baerlocher; Jay Silverberg
Journal:  Can Fam Physician       Date:  2005-05       Impact factor: 3.275

6.  Molecular and immunohistochemical effects of metformin in a rat model of type 2 diabetes mellitus.

Authors:  Tamer Ahmed Ismail; Mohamed Mohamed Soliman; Mohamed Abdo Nassan
Journal:  Exp Ther Med       Date:  2015-03-13       Impact factor: 2.447

7.  The effect of insulin resistance on prognosis of non-diabetic patients who underwent percutaneous coronary intervention.

Authors:  Kyeong Ho Yun; Myung Ho Jeong; Kye Hun Kim; Young Joon Hong; Hyung Wook Park; Ju Han Kim; Young Keun Ahn; Jeong Gwan Cho; Jong Chun Park; Nam Ho Kim; Seok Kyu Oh; Jin Won Jeong; Jung Chaee Kang
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

8.  Increased prevalence of subclinical atherosclerosis in rheumatoid arthritis patients of Indian descent.

Authors:  Sudha S Deo; Arun R Chogle; Kejal J Mistry; Rashmi R Shetty; Umakant L Nadkar
Journal:  Exp Clin Cardiol       Date:  2012

9.  Relationship of glycemic control, exogenous insulin, and C-peptide levels to ischemic heart disease mortality over a 16-year period in people with older-onset diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR).

Authors:  Flavio E Hirai; Scot E Moss; Barbara E K Klein; Ronald Klein
Journal:  Diabetes Care       Date:  2007-11-19       Impact factor: 19.112

Review 10.  Thiazolidinediones: effects on insulin resistance and the cardiovascular system.

Authors:  C E Quinn; P K Hamilton; C J Lockhart; G E McVeigh
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.